The United States and 11 other nations negotiating a free trade zone stretching from Chile to Japan failed to reach a final agreement at talks in Singapore, but indicated they were closing in on a landmark deal.
Hong Kong reported its second human case of H7N9 bird flu just days after the first, raising...
Hong Kong is on public-health alert after the city confirmed its first human case of the deadly...
As part of the realignment, Harvard Bioscience will reduce its global workforce by approximately 13 percent by eliminating certain operational redundancies across several sites, creating a leaner, more nimble organization. It plans to reinvest some of the savings into its China expansion, sales and marketing and product development initiatives, in order to drive growth.
JHL Biotech, Inc., a provider of biopharmaceutical process development and manufacturing services, and Switzerland-based Selexis SA, a provider of technologies for mammalian cell line development, announced today that they have signed a non-exclusive strategic agreement to provide biopharmaceutical customers a seamless solution for the development and cGMP manufacturing of biologic drugs.
Hong Kong has reported its first case of the H7N9 bird flu strain, in a possible sign the virus is spreading beyond mainland China since it first emerged there earlier this year. H7N9 was first identified April. It has sickened 139 people and killed 45 in China and Taiwan.
Who are the technical innovators in the US? The image we often have is that of the young Silicon Valley geek or the surfing California biopharma scientist -- sometimes brash and unafraid to challenge authority and champion new and better ideas.
GE Healthcare Life Sciences, and JHL Biotech today announced that GE Healthcare has completed installation of its FlexFactory™ biomanufacturing platform at JHL Biotech’s Research Center and manufacturing plant in Hsinchu, Taiwan. The new manufacturing platform will follow current good manufacturing practices (cGMP) and be fully operational by the end of 2013.
At least one person in Japan has been infected with HIV from a blood transfusion. A spokesman for the Japanese Red Cross Society said Tuesday that a male donor tested positive for HIV this month.
Mylan has announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product. The product is a biosimilar to Roche's Herceptin, indicated for the treatment of HER2 overexpressing breast cancer.
Merck KGaA, Darmstadt, Germany, has announced an € 80 million investment in a new pharmaceutical manufacturing facility, to be located in the Nantong Economical Technological Development Area (NETDA), in the Greater Shanghai region (Yangtze River Delta area).
The company said today it will spend $350 million to expand its insulin cartridge manufacturing in China, another $120 million for a similar improvement in France and $245 million to boost manufacturing capacity in Puerto Rico and Indianapolis.
A strain of bird flu that scientists thought could not infect people has shown up in a Taiwanese woman, a nasty surprise that shows scientists must do more to spot worrisome flu strains before they ignite a global outbreak, doctors say.
The Shiga University of Medical Science has become the third Japanese institution to conclude that a clinical study report on Novartis Pharma K.K.'s Diovan blood pressure-lowering drug contained doubtful data and was inappropriate, largely because a Novartis employee participated in the study.
WuXi PharmaTech announced today that the small molecule API and advanced intermediate manufacturing facility of WuXi's wholly owned subsidiary Shanghai SynTheAll Pharmaceutical Co. completed a general GMP and Pre-Approval Inspection from the FDA with no Form 483s issued.
Astellas Pharma Global Development, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, announces today the promotion of Mark Weinberg, M.D., MBA to Vice President of Global Clinical Science and the appointment of Robin J. McGarry, M.D. to the position of Vice President, Global Medical Safety Head.
AstraZeneca today announced that it has entered into an agreement with Janssen Pharmaceuticals K. K. in Japan to co-promote abiraterone acetate, an innovative oral therapy for the treatment of patients with prostate cancer.
A health ministry panel on Monday questioned Novartis Pharma K.K.'s use of clinical research data in promoting the sale of its blood pressure-lowering drug Diovan, saying it "could constitute misleading advertisement" following the revelation that some of the data was manipulated.
Medivir AB has reported that Janssen Pharmaceutical R&D Ireland (Janssen) has been informed by the Japanese Ministry of Health, Labour and Welfare (MHLW) that simeprevir has been approved for the treatment of genotype 1 chronic hepatitis C virus (HCV) infection.
Amgen and ShanghaiTech University today announced the two organizations have entered into a memorandum of understanding (MOU) to form a strategic partnership for the advancement of biopharmaceutical discovery and translational research in China. This agreement includes plans for Amgen to open a China research and development (R&D) center at ShanghaiTech University.
GE Healthcare Life Sciences to Build KUBio Modular Biopharmaceutical Factory for JHL Biotech in ChinaSeptember 25, 2013 8:07 am | News | Comments
GE Healthcare Life Sciences and JHL Biotech, a provider of biopharmaceutical process development and manufacturing services, today announced that a KUBio ™ modular biopharmaceutical factory will be built in China for JHL Biotech. The site for the new factory, which will be fully operational beginning early 2015, is the Biolake Science Park in Wuhan, China.
Shares in India's largest pharmaceutical company plummeted Monday after U.S. regulators issued an import warning on one of its factory's products for failing quality control inspections. Ranbaxy Laboratories Ltd. stock price fell by 30.3 percent to 318.40 rupees ($5.10) by the close of trading on the Bombay Stock Exchange.
The pharmaceutical giant Bayer AG confirmed Friday that it is being investigated in China for possible unfair competition, making it the latest foreign drug maker to come under scrutiny in the country. The Germany-based company said it is cooperating with Chinese authorities in the investigation...
ScinoPharm Taiwan Ltd. has announced that its Tainan, Taiwan Facility will provide the commercial manufacturing of topiramate active pharmaceutical ingredient for Trokendi XR™, a novel once-daily extended release formulation of topiramate for the treatment of epilepsy that was developed and recently launched by Supernus Pharmaceuticals in the U.S. market.
GlaxoSmithKline says it has sold its line of Lucozade and Ribena drinks brands to Suntory of Japan as part of the British company's effort to focus on its core pharmaceutical and health-care businesses.
The comments by officials of the European Chamber of Commerce in China follow announcements about fines imposed on dairy suppliers over pricing issues and an investigation into possibly bribery by employees of drug manufacturers GlaxoSmithKline and Sanofi.
Otsuka Pharmaceutical Co., Ltd. has announced an agreement with Astex Pharmaceuticals, Inc. to acquire Astex via an all-cash tender offer. The total purchase price of $866 million is based on the treasury stock calculation method and a tender offer of US $8.50 per share for all outstanding common shares.
Simcere Pharmaceutical Group plans to go private in a deal with a buyout group led by the Chinese drug developer's founder. Simcere said its board of directors has approved an agreement in which shareholders will receive $9.66 for each American Depositary Share, or ADS.
- Page 1